Astrazeneca stock closed at $76.21, up 0.74%, with positive outlook and industry rank top 29%.

From Nasdaq: 2025-02-28 18:15:08

Astrazeneca (AZN) closed at $76.21, up 0.74% from the previous day. Shares rose 6.19% in the past month, outperforming the Medical sector and S&P 500. Earnings per share expected to be $1.09 with revenue of $13.58 billion. Zacks Rank of #3 (Hold) and forward P/E ratio of 16.75.

Market watchers await Astrazeneca’s financial results, predicting EPS increase of 5.83% and revenue growth of 7.07%. Full-year estimates project earnings of $4.52 per share and revenue of $56.98 billion, reflecting positive business outlook. AZN trades at a discount with a PEG ratio of 1.45. Industry rank in top 29%.

Zacks Rank system shows positive estimate revisions correlate with stock prices. Industry Zacks Rank evaluates industry groups’ performance, with top 50% outperforming bottom half 2 to 1. Zacks.com tracks stock metrics, including Zacks Rank, to guide investment decisions.

Experts identify 7 top stocks for potential early price pops, beating the market by 2X since 1988 with an average gain of +24.3% per year. These elite stocks, selected from Zacks Rank #1 Strong Buys, warrant immediate attention for potential gains. Access the full list for profitable investment opportunities.



Read more at Nasdaq: Here’s Why Astrazeneca (AZN) Gained But Lagged the Market Today